ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0394

Predictors of quality of Life in a longitudinal cohort of patients with Uveitis, Juvenile Idiopathic Arthritis, and JIA-associated uveitis

andressa Guariento Ferreira Alves1, Amy Cassedy2, Virginia Miraldi Utz3, Alexandra Duell3, Megan Quinlan-Waters4, Nicole Reitz5, Sheila Angeles-Han6 and Melissa Lerman7, 1The Children's Hospital of Philadelphia, Philadelphia, PA, 2Cincinnati Children's hospital medical center, cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital Medical Center, CCHMC, 5Department of Mental Health, St. Louis, MO, 6Cincinnati Children's Hospital, Cincinnati, OH, 7Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: ACR Convergence 2025

Keywords: Eye Disorders, Juvenile idiopathic arthritis, Patient reported outcomes, Pediatric rheumatology, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0387–0429) Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Uveitis, juvenile idiopathic arthritis (JIA), and JIA-associated uveitis (JIA-U) greatly influence children’s quality of life (QOL). Our aim is to identify demographic, disease, and treatment features that may impact patient-reported outcomes (PROs) over time.

Methods: Patients with Uveitis, JIA, and JIA-U, and their caregivers enrolled in Longitudinal Outcomes of Childhood Uveitis Study (LOCUS) registry completed PROs as age-appropriate. The Effects of Youngsters’ Eyesight on Quality of Life (EYE-Q) measures vision-related QOL and function, and Pediatric Quality of Life Inventory (PedsQL) measures overall QOL. Scores range 0 -100 (higher scores: better QoL). The Revised Childhood Anxiety and Depression Scale (RCADS) assesses anxiety and depression. Scores >70 indicate anxiety or depression. The Childhood Health Assessment Questionnaire (C-HAQ) measures functional disability from JIA with scores range 0 -3 (higher scores: worse function). Generalized estimating equation models were used to identify predictors of QOL.

Results: A total of 19 (21.6%) patients with uveitis, 34 (38.7%) JIA-U and 35 (39.7%) JIA completed 5 visits. The median time between baseline and last visit was 19.7 mo (IQR:15.8-28.6). There was a predominance of female sex in JIA 23 (26.2%) and JIA-U 28 (31.8%) compared to Uveitis 8 (9.1%) (< 0.001). Disease duration was longer in JIA-U 5.2 (IQR: 1.5-9.0) vs. Uveitis 0.8 (IQR: 0.2-2.8) and JIA 1.2 (IQR: 0.5-2.5) (p< 0.001). Patients with uveitis alone and active JIA had worse EYE-Q scores (p < 0.01) compared to JIA-U. Not being on a DMARD, being > 10 y/o, and subsequent visits from baseline were significantly associated with better EYE-Q for parents only. Predictors of better PedsQL were not being on DMARD or NSAIDs, and male sex for parents and children. Those with any form of uveitis had worse PedsQL although only for parents. Patients >10 y/o with inactive arthritis or uveitis had better CHAQ for parents and patients. The use of DMARDs was not associated with CHAQ. RCADS better outcome predictors were male sex, for parents and patients, age < 10 y/o for patients and inactive JIA disease for parents.

Conclusion: Having a diagnosis of uveitis, even more so if it was an isolated disease, was associated with worse physical functioning and vision-related QOL/function and PedsQL. Overall predictors were similar between parents and patients with few differences. Male sex, not being on DMARDS or NSAID, and having inactive JIA were associated with better outcomes. Being >10 y/o was associated with better physical functioning and vision-related QOL/function but worse RCAD. Identification of key predictors that impact quality of life over time will help us begin to tailor interventions to enhance the wellbeing of patients with chronic arthritis and uveitis.

Supporting image 1Juvenile idiopathic arthritis associated uveitis (JIA-U); Juvenile idiopathic arthritis (JIA); nonsteroidal anti-inflammatory (NSAID); years (yrs); Intervale interquartile (IQR)

Bonferroni correction was used for multiple analysis

Supporting image 2Effects of Youngsters’ Eyesight on Quality of Life (EYE-Q); Pediatric Quality of Life Inventory (PedsQL); Juvenile idiopathic arthritis associated uveitis (JIA-U); Juvenile idiopathic arthritis (JIA); Disease-modifying antirheumatic drug (DMARD); nonsteroidal anti-inflammatory (NSAID); Least Square Mean scores (LS mean)

Pairwise analyses with Tukey’s correction for multiple analysis were significant for:

* JIA vs U and JIA-U vs U

‡JIA vs U

§ Time since baseline significant 7-11 and 18-24 in comparison with baseline

Supporting image 3Childhood Health Assessment Questionnaire (C-HAQ); The Revised Childhood Anxiety and Depression Scale (RCADS); Juvenile idiopathic arthritis associated uveitis (JIA-U); Juvenile idiopathic arthritis (JIA); Disease-modifying antirheumatic drug (DMARD); nonsteroidal anti-inflammatory (NSAID); Least Square Mean scores (LS mean)

Pairwise analyses with Tukey’s correction for multiple analysis were significant for:

* Baseline x 7-11 months visit

‡Baseline x 12-17 months visit


Disclosures: a. Guariento Ferreira Alves: None; A. Cassedy: None; V. Miraldi Utz: None; A. Duell: None; M. Quinlan-Waters: None; N. Reitz: None; S. Angeles-Han: None; M. Lerman: None.

To cite this abstract in AMA style:

Guariento Ferreira Alves a, Cassedy A, Miraldi Utz V, Duell A, Quinlan-Waters M, Reitz N, Angeles-Han S, Lerman M. Predictors of quality of Life in a longitudinal cohort of patients with Uveitis, Juvenile Idiopathic Arthritis, and JIA-associated uveitis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/predictors-of-quality-of-life-in-a-longitudinal-cohort-of-patients-with-uveitis-juvenile-idiopathic-arthritis-and-jia-associated-uveitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-quality-of-life-in-a-longitudinal-cohort-of-patients-with-uveitis-juvenile-idiopathic-arthritis-and-jia-associated-uveitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology